Free Trial

Kiniksa Pharmaceuticals (KNSA) SEC Filings & 10K Form

Kiniksa Pharmaceuticals logo
$26.95 +0.01 (+0.05%)
As of 02:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Kiniksa Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/05/2025
3:47 PM
Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:49 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:50 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:52 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:53 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:54 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:26 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:24 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
4:10 PM
Kiniksa Pharmaceuticals (Subject)
Moat Ross (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2025
4:11 PM
Kiniksa Pharmaceuticals (Subject)
Ragosa Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2025
3:15 PM
Kiniksa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2025
6:40 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
6:47 PM
BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/23/2025
3:31 PM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
3:44 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:30 PM
Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
04/16/2025
3:38 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
3:39 PM
Kiniksa Pharmaceuticals (Filer)
Form PRE 14A
04/09/2025
3:41 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:42 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:43 PM
Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:44 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:45 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:45 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
5:57 PM
Kiniksa Pharmaceuticals (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G
04/03/2025
4:06 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:52 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:35 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:48 PM
Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:49 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:50 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:51 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:52 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:53 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:29 PM
Kiniksa Pharmaceuticals (Subject)
Ragosa Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
3:37 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
3:38 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:47 PM
Kiniksa Pharmaceuticals (Subject)
Megna Michael R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
3:37 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:13 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
3:31 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.

Click here to see how you could take a stake in Elon’s private company…
02/25/2025
3:15 PM
Kiniksa Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
6:31 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
2:45 PM
Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:37 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:42 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:27 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:34 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
3:45 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
4:17 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:34 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
6:14 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:25 PM
Kiniksa Pharmaceuticals (Subject)
Ragosa Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
4:13 PM
Kiniksa Pharmaceuticals (Subject)
Megna Michael R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
4:50 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
3:32 PM
HHLR ADVISORS, LTD. (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
3:30 PM
Kiniksa Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G/A
11/06/2024
3:11 PM
Kiniksa Pharmaceuticals (Subject)
Patel Sanj K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
3:14 PM
Kiniksa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
6:31 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13G
10/17/2024
3:35 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:57 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
4:29 PM
BAKER BROS. ADVISORS LP (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13D/A
10/08/2024
4:08 PM
Boyd Meta Cantey (Reporting)
Kiniksa Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/08/2024
3:40 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:14 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kiniksa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:39 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
4:02 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:57 PM
Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:51 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:52 PM
Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:53 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:55 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:42 PM
Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
4:16 PM
Kiniksa Pharmaceuticals (Subject)
Paolini John F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
4:17 PM
Kiniksa Pharmaceuticals (Subject)
Moat Ross (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
3:36 PM
Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
4:17 PM
Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:31 PM
Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:32 PM
Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:33 PM
Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:10 PM
Kiniksa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2024
6:54 AM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/04/2024
11:15 PM
Kiniksa Pharmaceuticals (Filer)
Form EFFECT
07/04/2024
11:15 PM
Kiniksa Pharmaceuticals (Filer)
Form EFFECT
06/30/2024
11:15 PM
Kiniksa Pharmaceuticals (Filer)
Form EFFECT
06/28/2024
4:29 PM
Kiniksa Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/28/2024
4:30 PM
Kiniksa Pharmaceuticals (Filer)
Form 15-15D
06/28/2024
4:22 PM
Kiniksa Pharmaceuticals (Filer)
Form POS AM
06/28/2024
4:22 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
Trump wipes out trillions overnight… (Ad)

Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.

Whether you take some of that wealth for yourself depends on if you watch this controversial exposé
06/28/2024
4:23 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:23 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:24 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:24 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:25 PM
Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/27/2024
8:34 PM
Kiniksa Pharmaceuticals (Filer)
Form POS AM
06/25/2024
3:30 PM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:27 PM
Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
3:35 PM
Kiniksa Pharmaceuticals (Issuer)
Quart Barry D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KNSA) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners